Wednesday, February 10, 2010, 9:17am EST - Canadian Markets open in 13 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Vanda Pharmaceuticals, Inc. (VNDA)

 On Feb 9: 10.60 USD   0.00 (0.00%)  
MORE ON VNDA
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Vanda Pharmaceuticals Inc. (NGM:VNDA) Delayed quote dataEdit
Last Trade: 10.60 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 10.60
Open: N/A
Bid: 10.25 x 100
Ask: 10.88 x 300
1y Target Est: 19.67
Day's Range: N/A - N/A
52wk Range: 0.60 - 16.65
Volume: 0
Avg Vol (3m): 461,687
Market Cap: 288.33M
P/E (ttm): N/A
EPS (ttm): -2.58
Div & Yield: N/A (N/A%)
Vanda Pharmaceuticals, Inc. (VNDA)
1d  5d  3m  6m  1y  2y  5y 
 Add VNDA to Portfolio   Download Data

HEADLINES
• Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on February 16, 2010
PRNewswire (Tue 2:09pm)
• These Stocks Can Easily Double Your Money
at Motley Fool (Wed, Jan 20)
• Competitive Schizophrenia Market
Zacks.com (Tue, Jan 12)
• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
EDGAR Online (Mon, Jan 11)
• Drug News: Impotence, Arthritis and Schizophrenia
at The Wall Street Journal Online (Mon, Jan 11)
• Sales start for Vanda Pharmaceuticals schizophrenia treatment
at bizjournals.com (Mon, Jan 11)
• Fanapt(TM) Launches in the U.S.
PRNewswire (Mon, Jan 11)
• Biotech's Movers and Shakers 2009: BioBuzz
at TheStreet.com (Mon, Jan 4)
• Biotech's Movers & Shakers 2009: BioBuzz
at TheStreet.com (Mon, Jan 4)
• Biotech's 2009 Movers & Shakers: BioBuzz
at TheStreet.com (Mon, Jan 4)
• Nasdaq 2009 Winners & Losers
at TheStreet.com (Thu, Dec 31)
• Millennial Stocks - Up By Over 1,000% In 2009
at Investopedia (Thu, Dec 31)
More Headlines for VNDA...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.9
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Vanda Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of clinical-stage drug candidates for various central nervous system disorders.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices